Doxorubicin enhances (131)I-rituximab induced cell death in Raji cells.
Journal:
Journal of cancer research and therapeutics
PMID:
26881525
Abstract
AIM: There are various therapeutic modalities of treatment for non-Hodgkin's lymphoma, but with certain limitations, hence, investigating the scope of combined therapeutic approach.
Authors
Keywords
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Blotting, Western
Burkitt Lymphoma
Cell Proliferation
Doxorubicin
Drug Synergism
Flow Cytometry
Humans
Iodine Radioisotopes
Poly(ADP-ribose) Polymerases
Radiation-Sensitizing Agents
Radiopharmaceuticals
Rituximab
RNA, Messenger
Signal Transduction
Tumor Cells, Cultured